{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:45:20Z","timestamp":1792197920069,"version":"4.4.0"},"reference-count":187,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Tumor-associated macrophages (TAMs) are a dominant immune component within the glioma microenvironment and are increasingly recognized as key contributors to therapeutic resistance, the major challenge in glioma management. Understanding their role is critical for developing novel therapies. This review synthesizes current knowledge on TAM-mediated chemoresistance in glioma. TAMs originate from bone marrow-derived monocytes and resident microglia, exhibiting significant heterogeneity and plasticity, particularly between pro-inflammatory (M1) and pro-tumorigenic (M2) phenotypes. M2-like TAMs drive resistance through multiple mechanisms: (1) Modulating drug metabolism\/clearance (e.g., via CYP450 enzymes and P-glycoprotein); (2) Secreting protumor factors (TNF-\u03b1, ILs like IL-4\/IL-6\/IL-10, chemokines like CCL5\/CCL22, growth factors like VEGF\/EGF) that activate survival pathways, induce immunosuppression, promote angiogenesis, and enhance epithelial-mesenchymal transition (EMT); (3) Interacting with glioma stem cells (GSCs) to maintain stemness; (4) Facilitating microenvironmental adaptation (e.g., hypoxia\/HIF-1\u03b1 response); (5) Remodeling the extracellular matrix (ECM) via MMPs, increasing stiffness and impairing drug penetration. Targeting TAMs offers promising approaches to overcome resistance. Strategies include: (1) Reprogramming M2 to M1 phenotypes using agonists (TLR, STING, CD40) or inhibitors (STAT3\/STAT6); (2) Metabolic modulation (targeting glycolysis, fatty acid oxidation, glutaminolysis); (3) Blocking recruitment axes (CCL2\/CCR2, CSF-1\/CSF-1R, CXCL12\/CXCR4); (4) Depleting M2-TAMs (e.g., trabectedin, CAR-T cells, M2pep-drugs); (5) Enhancing phagocytosis (anti-SIRP\u03b1\/CD47, anti-SIGLEC). TAMs are pivotal mediators of chemoresistance in glioma through diverse molecular and cellular mechanisms. Targeting TAM recruitment, polarization, function, or metabolism represents a promising therapeutic avenue. However, the complexity of the glioma microenvironment and blood-brain barrier necessitate combination strategies for clinical translation. Further research is needed to optimize specificity and overcome challenges like compensatory pathways and drug delivery.<\/jats:p>","DOI":"10.3389\/fcell.2025.1676338","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T05:30:42Z","timestamp":1758864642000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Advances in tumor-associated macrophage-mediated chemotherapeutic resistance in glioma"],"prefix":"10.3389","volume":"13","author":[{"given":"Xuebo","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"eaaw7843","DOI":"10.1126\/scitranslmed.aaw7843","article-title":"Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance","volume":"12","author":"Akkari","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.3390\/cancers14051319","article-title":"Tumor-associated macrophages in gliomas-basic insights and treatment opportunities","volume":"14","author":"Andersen","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.1158\/0008-5472.CAN-14-3499","article-title":"Suppression of intratumoral CCL22 by type i interferon inhibits migration of regulatory T cells and blocks cancer progression","volume":"75","author":"Anz","year":"2015","journal-title":"Cancer Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","article-title":"CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy","volume":"572","author":"Barkal","year":"2019","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"669474","DOI":"10.3389\/fimmu.2021.669474","article-title":"Differentiation and regulation of T(H) cells: a balancing act for cancer immunotherapy","volume":"12","author":"Basu","year":"2021","journal-title":"Front. Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13046-022-02251-2","article-title":"Immunotherapy for glioblastoma: the promise of combination strategies","volume":"41","author":"Bausart","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1126\/science.1198443","article-title":"CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans","volume":"331","author":"Beatty","year":"2011","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41423-023-01061-6","article-title":"Roles of macrophages in tumor development: a spatiotemporal perspective","volume":"20","author":"Bied","year":"2023","journal-title":"Cell Mol. Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"6995","DOI":"10.3390\/ijms22136995","article-title":"Macrophage polarization states in the tumor microenvironment","volume":"22","author":"Boutilier","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.semcancer.2022.06.002","article-title":"Chemokines and chemokine receptors in colorectal cancer; multifarious roles and clinical impact","volume":"86","author":"Braoudaki","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20171038","article-title":"miR-6743-5p, as a direct upstream regulator of GRIM-19, enhances proliferation and suppresses apoptosis in glioma cells","volume":"37","author":"Cao","year":"2017","journal-title":"Biosci. Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"14667","DOI":"10.3390\/ijms232314667","article-title":"Regulation of P-Glycoprotein in the brain","volume":"23","author":"Chai","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"107986","DOI":"10.1016\/j.pharmthera.2021.107986","article-title":"Modulating tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors: a TAM-Pting approach","volume":"231","author":"Chamseddine","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","article-title":"Tumor-associated macrophages: an accomplice in solid tumor progression","volume":"26","author":"Chen","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1631\/jzus.B2000808","article-title":"Toll-like receptor 3 (TLR3) regulation mechanisms and roles in antiviral innate immune responses","volume":"22","author":"Chen","year":"2021","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"B16","doi-asserted-by":"publisher","first-page":"101177","DOI":"10.1016\/j.xcrm.2023.101177","article-title":"Tumor-associated monocytes promote mesenchymal transformation through EGFR signaling in glioma","volume":"4","author":"Chen","year":"2023","journal-title":"Cell Rep. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40364-023-00551-z","article-title":"Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy","volume":"12","author":"Chen","year":"2024","journal-title":"Biomark. Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"101441","DOI":"10.1016\/j.mtbio.2024.101441","article-title":"Functionalized biomimetic nanoparticles loaded with salvianolic acid B for synergistic targeted triple-negative breast cancer treatment","volume":"30","author":"Cheng","year":"2025","journal-title":"Mater Today Bio"},{"key":"B19","doi-asserted-by":"publisher","first-page":"122076","DOI":"10.1016\/j.biomaterials.2023.122076","article-title":"Tumor-associated macrophages induce inflammation and drug resistance in a mechanically tunable engineered model of osteosarcoma","volume":"296","author":"Chim","year":"2023","journal-title":"Biomaterials"},{"key":"B20","doi-asserted-by":"publisher","first-page":"11085","DOI":"10.1038\/s41598-019-47438-4","article-title":"Increased antiangiogenic effect by blocking CCL2-dependent macrophages in a rodent glioblastoma model: correlation study with dynamic susceptibility contrast perfusion MRI","volume":"9","author":"Cho","year":"2019","journal-title":"Sci. Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/life11010069","article-title":"Tricarboxylic acid (TCA) cycle intermediates: regulators of immune responses","volume":"11","author":"Choi","year":"2021","journal-title":"Life (Basel)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12943-024-02064-1","article-title":"Decoding the spatiotemporal heterogeneity of tumor-associated macrophages","volume":"23","author":"Chu","year":"2024","journal-title":"Mol. Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"7575","DOI":"10.3390\/ijms22147575","article-title":"TGF-\u03b2 signaling: from tissue fibrosis to tumor microenvironment","volume":"22","author":"Chung","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"5930","DOI":"10.3390\/cancers14235930","article-title":"Role of the hypoxic-secretome in seed and soil metastatic preparation","volume":"14","author":"Clemente-Gonz\u00e1lez","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13402-019-00489-1","article-title":"The dual role of tumor necrosis factor-alpha (TNF-alpha) in breast cancer: molecular insights and therapeutic approaches","volume":"43","author":"Cruceriu","year":"2020","journal-title":"Cell Oncol. (Dordr)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e2212813120","DOI":"10.1073\/pnas.2212813120","article-title":"HDAC7 is an immunometabolic switch triaging danger signals for engagement of antimicrobial versus inflammatory responses in macrophages","volume":"120","author":"Das Gupta","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/13543776.2021.1839414","article-title":"Small-molecule CSF1R kinase inhibitors; review of patents 2015-present","volume":"31","author":"Denny","year":"2021","journal-title":"Expert Opin. Ther. Pat."},{"key":"B28","doi-asserted-by":"publisher","first-page":"101272","DOI":"10.1016\/j.drup.2025.101272","article-title":"Metabolic reprogramming of tumor-associated macrophages via adenosine-A(2A)R signaling drives cross-resistance in non-small cell lung cancer","volume":"82","author":"Ding","year":"2025","journal-title":"Drug Resist Updat"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s41597-025-05619-z","article-title":"High-resolution ultrasound data for AI-Based segmentation in mouse brain tumor","volume":"12","author":"Dorosti","year":"2025","journal-title":"Sci. Data"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1080\/14712598.2021.1934446","article-title":"Rationale and clinical development of CD40 agonistic antibodies for cancer immunotherapy","volume":"21","author":"Enell Smith","year":"2021","journal-title":"Expert Opin. Biol. Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.3390\/antiox11081488","article-title":"Glycolysis and the pentose phosphate pathway promote LPS-induced NOX2 Oxidase- and IFN-beta-Dependent inflammation in macrophages","volume":"11","author":"Erlich","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"112658","DOI":"10.1016\/j.celrep.2023.112658","article-title":"Dimethyl itaconate induces long-term innate immune responses and confers protection against infection","volume":"42","author":"Ferreira","year":"2023","journal-title":"Cell Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.annpat.2021.11.005","article-title":"The 2021 WHO classification of tumours of the central nervous system","volume":"42","author":"Figarella-Branger","year":"2022","journal-title":"Ann. Pathol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"7803091","DOI":"10.1155\/2016\/7803091","article-title":"Crosstalk between innate lymphoid cells and other immune cells in the tumor microenvironment","volume":"2016","author":"Flores-Borja","year":"2016","journal-title":"J. Immunol. Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"966458","DOI":"10.3389\/fmed.2022.966458","article-title":"Development of immunotherapy for high-grade gliomas: overcoming the immunosuppressive tumor microenvironment","volume":"9","author":"Franson","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1016\/j.cell.2021.03.023","article-title":"Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion","volume":"184","author":"Gangoso","year":"2021","journal-title":"Cell"},{"key":"B37","doi-asserted-by":"publisher","first-page":"5263","DOI":"10.1038\/s41467-025-60422-z","article-title":"A self-directed Trojanbot-enzymatic nanobot in neutrobot for active target therapy of glioblastoma","volume":"16","author":"Gao","year":"2025","journal-title":"Nat. Commun."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.ccell.2021.04.011","article-title":"Interleukin-1 in tumor progression, therapy, and prevention","volume":"39","author":"Garlanda","year":"2021","journal-title":"Cancer Cell"},{"key":"B39","doi-asserted-by":"publisher","first-page":"771835","DOI":"10.3389\/fmolb.2021.771835","article-title":"A review on the role of miR-1246 in the pathoetiology of different cancers","volume":"8","author":"Ghafouri-Fard","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1017\/erm.2022.8","article-title":"Tumour-associated macrophages heterogeneity drives resistance to clinical therapy","volume":"24","author":"Guo","year":"2022","journal-title":"Expert Rev. Mol. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"104161","DOI":"10.1016\/j.drudis.2024.104161","article-title":"P-glycoprotein (P-gp)-driven cancer drug resistance: biological profile, non-coding RNAs, drugs and nanomodulators","volume":"29","author":"Guo","year":"2024","journal-title":"Drug Discov. Today"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1497026","DOI":"10.3389\/fimmu.2024.1497026","article-title":"The role and therapeutic targeting of the CCL2\/CCR2 signaling axis in inflammatory and fibrotic diseases","volume":"15","author":"Guo","year":"2024","journal-title":"Front. Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00018-022-04225-1","article-title":"Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges","volume":"79","author":"Han","year":"2022","journal-title":"Cell Mol. Life Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.3390\/cancers14143331","article-title":"The role of metabolic plasticity of tumor-associated macrophages in shaping the tumor microenvironment immunity","volume":"14","author":"Hasan","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B45","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1158\/0008-5472.CAN-13-3461","article-title":"Immune-based antitumor effects of BRAF inhibitors rely on signaling by CD40L and IFN\u03b3","volume":"74","author":"Ho","year":"2014","journal-title":"Cancer Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12985-022-01937-5","article-title":"The mechanisms and cross-protection of trained innate immunity","volume":"19","author":"Hu","year":"2022","journal-title":"Virol. J."},{"key":"B47","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s12672-025-02195-x","article-title":"Role of M2 macrophage-derived exosomes in cancer drug resistance via noncoding RNAs","volume":"16","author":"Hu","year":"2025","journal-title":"Discov. Oncol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41419-020-2435-y","article-title":"CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating beta-catenin\/STAT3 signaling","volume":"11","author":"Huang","year":"2020","journal-title":"Cell Death Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1049\/nbt2.12009","article-title":"Graphene oxide-ellagic acid nanocomposite as effective anticancer and antimicrobial agent","volume":"15","author":"Hussein-Al-Ali","year":"2021","journal-title":"IET Nanobiotechnol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.2217\/nnm-2020-0106","article-title":"Trojan horse monocyte-mediated delivery of conjugated polymer nanoparticles for improved photodynamic therapy of glioblastoma","volume":"15","author":"Ibarra","year":"2020","journal-title":"Nanomedicine (Lond)"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.3390\/ijms22052719","article-title":"The role of tumor necrosis factor alpha (TNF-alpha) in autoimmune disease and current TNF-alpha inhibitors in therapeutics","volume":"22","author":"Jang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.canlet.2020.10.050","article-title":"Clinical practice guidelines for the management of adult diffuse gliomas","volume":"499","author":"Jiang","year":"2021","journal-title":"Cancer Lett."},{"key":"B53","doi-asserted-by":"publisher","first-page":"886996","DOI":"10.3389\/fmed.2022.886996","article-title":"Berberine as a potential agent for the treatment of colorectal cancer","volume":"9","author":"Jiang","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"B54","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ibneur.2025.01.015","article-title":"Exploring the roles and clinical potential of exosome-derived non-coding RNAs in glioma","volume":"18","author":"Jin","year":"2025","journal-title":"IBRO Neurosci. Rep."},{"key":"B55","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12964-024-01555-4","article-title":"Discovery of a novel small molecule as CD47\/SIRP\u03b1 and PD-1\/PD-L1 dual inhibitor for cancer immunotherapy","volume":"22","author":"Jin","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"B56","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/cas.16447","article-title":"IGFBP2 promotes proliferation and glycolysis of endometrial cancer by regulating PKM2\/HIF-1\u03b1 axis","volume":"116","author":"Jin","year":"2025","journal-title":"Cancer Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.4049\/jimmunol.1402797","article-title":"Transcription factors STAT6 and KLF4 implement macrophage polarization via the dual catalytic powers of MCPIP","volume":"194","author":"Kapoor","year":"2015","journal-title":"J. Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.biochi.2019.08.003","article-title":"Role of AKT and mTOR signaling pathways in the induction of epithelial-mesenchymal transition (EMT) process","volume":"165","author":"Karimi Roshan","year":"2019","journal-title":"Biochimie"},{"key":"B59","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/ijmm.2016.2620","article-title":"FGFR inhibitors: effects on cancer cells, tumor microenvironment and whole-body homeostasis (review)","volume":"38","author":"Katoh","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"101891","DOI":"10.1016\/j.redox.2021.101891","article-title":"Immune cell - produced ROS and their impact on tumor growth and metastasis","volume":"42","author":"Kennel","year":"2021","journal-title":"Redox Biol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"e163446","DOI":"10.1172\/JCI163446","article-title":"Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy","volume":"133","author":"Khan","year":"2023","journal-title":"J. Clin. Invest"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1166487","DOI":"10.3389\/fimmu.2023.1166487","article-title":"Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy","volume":"14","author":"Khan","year":"2023","journal-title":"Front. Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"85021","DOI":"10.18632\/oncotarget.13116","article-title":"EGF induces epithelial-mesenchymal transition through phospho-Smad2\/3-Snail signaling pathway in breast cancer cells","volume":"7","author":"Kim","year":"2016","journal-title":"Oncotarget"},{"key":"B64","doi-asserted-by":"publisher","first-page":"6701","DOI":"10.3390\/ijms24076701","article-title":"The role of toll-like receptors (TLRs) and their related signaling pathways in viral infection and inflammation","volume":"24","author":"Kircheis","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1158\/1535-7163.MCT-11-0801","article-title":"STAT3 inhibition overcomes temozolomide resistance in glioblastoma by downregulating MGMT expression","volume":"11","author":"Kohsaka","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"B66","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/path.2370","article-title":"Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas","volume":"216","author":"Komohara","year":"2008","journal-title":"J. Pathol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1016\/j.celrep.2017.02.006","article-title":"Extracellular acidic pH activates the sterol regulatory element-binding protein 2 to promote tumor progression","volume":"18","author":"Kondo","year":"2017","journal-title":"Cell Rep."},{"key":"B68","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3390\/pharmaceutics16050636","article-title":"Reprogramming tumor-associated macrophage using nanocarriers: new perspectives to halt cancer progression","volume":"16","author":"Kuznetsova","year":"2024","journal-title":"Pharmaceutics"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1596004","DOI":"10.1080\/2162402X.2019.1596004","article-title":"Interaction of tumor-associated macrophages and cancer chemotherapy","volume":"8","author":"Larionova","year":"2019","journal-title":"Oncoimmunology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"19915","DOI":"10.1038\/s41598-023-46968-2","article-title":"Anti-CCL2 antibody combined with etoposide prolongs survival in a minimal residual disease mouse model of neuroblastoma","volume":"13","author":"Lascano","year":"2023","journal-title":"Sci. Rep."},{"key":"B71","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.immuni.2019.11.009","article-title":"Toll-like receptor signaling rewires macrophage metabolism and promotes histone acetylation via ATP-citrate lyase","volume":"51","author":"Lauterbach","year":"2019","journal-title":"Immunity"},{"key":"B72","doi-asserted-by":"publisher","first-page":"110865","DOI":"10.1016\/j.celrep.2022.110865","article-title":"Tumor-associated macrophage heterogeneity is driven by tissue territories in breast cancer","volume":"39","author":"Laviron","year":"2022","journal-title":"Cell Rep."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s12672-025-02912-6","article-title":"A novel cuproptosis-associated LncRNA model predicting prognostic and immunotherapy response for glioma","volume":"16","author":"Lei","year":"2025","journal-title":"Discov. Oncol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2115655","DOI":"10.1080\/2162402X.2022.2115655","article-title":"CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment","volume":"11","author":"Lecoq","year":"2022","journal-title":"Oncoimmunology"},{"key":"B75","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.3390\/ijms22073315","article-title":"Mitochondrial fuel dependence on glutamine drives chemo-resistance in the cancer stem cells of hepatocellular carcinoma","volume":"22","author":"Lee","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B76","doi-asserted-by":"publisher","first-page":"114504","DOI":"10.1016\/j.biopha.2023.114504","article-title":"The role of metabolic reprogramming of tumor-associated macrophages in shaping the immunosuppressive tumor microenvironment","volume":"161","author":"Li","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"B77","doi-asserted-by":"publisher","first-page":"e001341","DOI":"10.1136\/jitc-2020-001341","article-title":"Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer","volume":"9","author":"Li","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"B78","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13578-022-00823-5","article-title":"Targeting tumor-associated macrophages for cancer treatment","volume":"12","author":"Li","year":"2022","journal-title":"Cell Biosci."},{"key":"B79","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41419-024-06888-z","article-title":"Biological impact and therapeutic implication of tumor-associated macrophages in hepatocellular carcinoma","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"key":"B80","doi-asserted-by":"publisher","first-page":"110704","DOI":"10.1016\/j.cclet.2024.110704","article-title":"Sequential-gated transformable nanoprodrug potentiates antitumor immunity through TME modulation and STING activation","volume":"36","author":"Li, Y","year":"2024","journal-title":"Chin. Chem. Lett."},{"key":"B81","doi-asserted-by":"publisher","first-page":"20240027","DOI":"10.1002\/EXP.20240027","article-title":"Bioengineer mesenchymal stem cell for treatment of glioma by IL-12 mediated microenvironment reprogramming and nCD47-SLAMF7 mediated phagocytosis regulation of macrophages","volume":"4","author":"Li","year":"2024","journal-title":"Explor. (Beijing)"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e00738","DOI":"10.1002\/adbi.202400738","article-title":"Inhibition of glutamine metabolism attenuates tumor progression through remodeling of the macrophage immune microenvironment","author":"Li","year":"2025","journal-title":"Adv. Biol. (Weinh)"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1161\/ATVBAHA.123.318237","article-title":"Extracellular matrix remodeling in vascular disease: defining its regulators and pathological influence","volume":"43","author":"Lin","year":"2023","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/ni.3796","article-title":"\u03b1-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming","volume":"18","author":"Liu","year":"2017","journal-title":"Nat. Immunol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13045-019-0770-1","article-title":"Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy","volume":"12","author":"Liu","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/s41419-020-03161-x","article-title":"Tumor necrosis factor alpha inhibition overcomes immunosuppressive M2b macrophage-induced bevacizumab resistance in triple-negative breast cancer","volume":"11","author":"Liu","year":"","journal-title":"Cell Death Dis."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1038\/s41418-019-0460-0","article-title":"Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65\/STAT3-CSN5-PD-L1 pathway","volume":"27","author":"Liu","year":"","journal-title":"Cell Death Differ."},{"key":"B88","doi-asserted-by":"publisher","first-page":"e002548","DOI":"10.1136\/jitc-2021-002548","article-title":"S100A4 enhances protumor macrophage polarization by control of PPAR-\u03b3-dependent induction of fatty acid oxidation","volume":"9","author":"Liu","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1111\/cns.13892","article-title":"Hypoxia-induced polypoid giant cancer cells in glioma promote the transformation of tumor-associated macrophages to a tumor-supportive phenotype","volume":"28","author":"Liu","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"B90","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41590-023-01430-3","article-title":"CD40 signal rewires fatty acid and glutamine metabolism for stimulating macrophage anti-tumorigenic functions","volume":"24","author":"Liu","year":"2023","journal-title":"Nat. Immunol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3892\/ijo.2024.5684","article-title":"Drug resistance and tumor immune microenvironment: an overview of current understandings (review)","volume":"65","author":"Liu","year":"","journal-title":"Int. J. Oncol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jare.2023.10.009","article-title":"Deciphering the role of CD47 in cancer immunotherapy","volume":"63","author":"Liu","year":"","journal-title":"J. Adv. Res."},{"key":"B93","doi-asserted-by":"publisher","first-page":"189344","DOI":"10.1016\/j.bbcan.2025.189344","article-title":"Interactions between cancer cells and tumor-associated macrophages in tumor microenvironment","volume":"1880","author":"Liu","year":"","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B94","doi-asserted-by":"publisher","first-page":"0133","DOI":"10.34133\/bmr.0133","article-title":"Combined strategies for nanodrugs noninvasively overcoming the blood-brain barrier and actively targeting glioma lesions","volume":"29","author":"Liu","year":"","journal-title":"Biomater. Res."},{"key":"B95","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.3390\/ijms22073765","article-title":"Anti-angiogenic therapy: current challenges and future perspectives","volume":"22","author":"Lopes-Coelho","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B96","doi-asserted-by":"publisher","first-page":"44612","DOI":"10.1038\/srep44612","article-title":"Effect of modulation of PPAR-\u03b3 activity on kupffer cells M1\/M2 polarization in the development of non-alcoholic fatty liver disease","volume":"7","author":"Luo","year":"2017","journal-title":"Sci. Rep."},{"key":"B97","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.3892\/mmr.2018.9486","article-title":"Modular bioinformatics analysis demonstrates that a toll-like receptor signaling pathway is involved in the regulation of macrophage polarization","volume":"18","author":"Ma","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"B98","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"B99","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1080\/13543784.2024.2388567","article-title":"Investigational CXCR4 inhibitors in early phase development for the treatment of hematological malignancies","volume":"33","author":"Martino","year":"2024","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.biopha.2018.09.177","article-title":"The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer","volume":"108","author":"Masjedi","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/s43018-023-00598-9","article-title":"Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response","volume":"4","author":"Mei","year":"2023","journal-title":"Nat. Cancer"},{"key":"B102","doi-asserted-by":"publisher","first-page":"7820","DOI":"10.1073\/pnas.1218599110","article-title":"Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production","volume":"110","author":"Michelucci","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B103","doi-asserted-by":"publisher","first-page":"725473","DOI":"10.3389\/fcell.2021.725473","article-title":"The TNF-\u03b1\/TNFR2 pathway: targeting a brake to release the anti-tumor immune response","volume":"9","author":"Moatti","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3390\/cancers15030971","article-title":"Targeted therapy of Interleukin-34 as a promising approach to overcome cancer therapy resistance","volume":"15","author":"Monteleone","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B105","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s12672-025-01996-4","article-title":"Probiotics in colorectal cancer prevention and therapy: mechanisms, benefits, and challenges","volume":"16","author":"Morsli","year":"2025","journal-title":"Discov. Oncol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1111\/cas.15722","article-title":"Metabolic adaptations of cancer in extreme tumor microenvironments","volume":"114","author":"Nakahara","year":"2023","journal-title":"Cancer Sci."},{"key":"B107","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.it.2023.10.007","article-title":"Tumor macrophage functional heterogeneity can inform the development of novel cancer therapies","volume":"44","author":"Nasir","year":"2023","journal-title":"Trends Immunol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jconrel.2015.12.057","article-title":"Synthesis and evaluation of multivalent M2pep peptides for targeting alternatively activated M2 macrophages","volume":"224","author":"Ngambenjawong","year":"2016","journal-title":"J. Control Release"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1353787","DOI":"10.3389\/fimmu.2024.1353787","article-title":"Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy","volume":"15","author":"Nicolini","year":"2024","journal-title":"Front. Immunol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1172\/JCI131859","article-title":"Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells","volume":"130","author":"Oh","year":"2020","journal-title":"J. Clin. Invest"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1002\/1873-3468.70039","article-title":"The power of microRNA regulation-insights into immunity and metabolism","volume":"599","author":"Oliveto","year":"2025","journal-title":"FEBS Lett."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/j.celrep.2017.07.054","article-title":"Pharmacologic or genetic targeting of glutamine synthetase skews macrophages toward an M1-like phenotype and inhibits tumor metastasis","volume":"20","author":"Palmieri","year":"2017","journal-title":"Cell Rep."},{"key":"B113","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1038\/s41388-025-03453-6","article-title":"BRD4 regulates PAI-1 expression in tumor-associated macrophages to drive chemoresistance in colorectal cancer","volume":"44","author":"Pan","year":"2025","journal-title":"Oncogene"},{"key":"B114","doi-asserted-by":"publisher","first-page":"104061","DOI":"10.1016\/j.drudis.2024.104061","article-title":"Molecular insights to therapeutic in cancer: role of exosomes in tumor microenvironment, metastatic progression and drug resistance","volume":"29","author":"Panda","year":"2024","journal-title":"Drug Discov. Today"},{"key":"B115","doi-asserted-by":"publisher","first-page":"114267","DOI":"10.1016\/j.ejpb.2024.114267","article-title":"Exploring the potential of P-glycoprotein inhibitors in the targeted delivery of anti-cancer drugs: a comprehensive review","volume":"198","author":"Patel","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"B116","doi-asserted-by":"publisher","first-page":"117187","DOI":"10.1016\/j.bcp.2025.117187","article-title":"Recent advances in colony stimulating factor-1 receptor (CSF1R) inhibitors","volume":"242","author":"Peng","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1007\/s10637-012-9869-8","article-title":"Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer","volume":"31","author":"Pienta","year":"2013","journal-title":"Invest New Drugs"},{"key":"B118","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41388-019-0996-y","article-title":"Hypoxic glioma-derived exosomes deliver microRNA-1246 to induce M2 macrophage polarization by targeting TERF2IP via the STAT3 and NF-\u03baB pathways","volume":"39","author":"Qian","year":"2020","journal-title":"Oncogene"},{"key":"B119","doi-asserted-by":"publisher","first-page":"112707","DOI":"10.1016\/j.intimp.2024.112707","article-title":"Anti-tumor effects of telmisartan in glioma-astrocyte non-contact co-cultures: a critical role of astrocytic IL-6-mediated paracrine growth promotion","volume":"139","author":"Quan","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41467-021-20893-2","article-title":"CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy","volume":"12","author":"Rodriguez-Garcia","year":"2021","journal-title":"Nat. Commun."},{"key":"B121","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41698-023-00364-1","article-title":"Applications and clinical trial landscape using toll-like receptor agonists to reduce the toll of cancer","volume":"7","author":"Rolfo","year":"2023","journal-title":"NPJ Precis. Oncol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13046-022-02349-7","article-title":"Emerging therapies for glioblastoma: current state and future directions","volume":"41","author":"Rong","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B123","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00281-023-00988-2","article-title":"The role of macrophages in the tumor microenvironment and tumor metabolism","volume":"45","author":"Sadhukhan","year":"2023","journal-title":"Semin. Immunopathol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"e178146","DOI":"10.1172\/jci.insight.178146","article-title":"Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages","volume":"10","author":"Sato","year":"2025","journal-title":"JCI Insight"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.ccell.2022.08.012","article-title":"Increased glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal cathepsin B to promote cancer metastasis and chemoresistance","volume":"40","author":"Shi","year":"2022","journal-title":"Cancer Cell"},{"key":"B126","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41392-024-01885-2","article-title":"Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives","volume":"9","author":"Shi","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1518664","DOI":"10.3389\/fimmu.2025.1518664","article-title":"NF-\u03baB signaling and the tumor microenvironment in osteosarcoma: implications for immune evasion and therapeutic resistance","volume":"16","author":"Shi","year":"2025","journal-title":"Front. Immunol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41467-019-14263-2","article-title":"Macrophages directly contribute collagen to scar formation during zebrafish heart regeneration and mouse heart repair","volume":"11","author":"Simoes","year":"2020","journal-title":"Nat. Commun."},{"key":"B129","doi-asserted-by":"publisher","first-page":"e002181","DOI":"10.1136\/jitc-2020-002181","article-title":"Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma","volume":"9","author":"Simonds","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"B130","doi-asserted-by":"publisher","first-page":"5497","DOI":"10.3390\/ijms21155497","article-title":"Targeting of CD163(+) macrophages in inflammatory and malignant diseases","volume":"21","author":"Skytthe","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1027235","DOI":"10.3389\/fimmu.2022.1027235","article-title":"Inhibition of the CD47-SIRP\u03b1 axis for cancer therapy: a systematic review and meta-analysis of emerging clinical data","volume":"13","author":"Son","year":"2022","journal-title":"Front. Immunol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.3390\/cancers15061642","article-title":"The role of different immunocompetent cell populations in the pathogenesis of head and neck cancer-regulatory mechanisms of Pro- and anti-cancer activity and their impact on immunotherapy","volume":"15","author":"Starska-Kowarska","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B133","doi-asserted-by":"publisher","first-page":"8707","DOI":"10.3390\/ijms24108707","article-title":"The tango between cancer-associated fibroblasts (CAFs) and immune cells in affecting immunotherapy efficacy in pancreatic cancer","volume":"24","author":"Stouten","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.3390\/cancers14051342","article-title":"Hemodynamic imaging in cerebral diffuse glioma-part B: molecular correlates, treatment effect monitoring, prognosis, and future directions","volume":"14","author":"Stumpo","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1158\/0008-5472.CAN-19-2994","article-title":"Enhanced lipid accumulation and metabolism are required for the differentiation and activation of tumor-associated macrophages","volume":"80","author":"Su","year":"2020","journal-title":"Cancer Res."},{"key":"B136","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/jb\/mvad086","article-title":"Identification of effective CCR2 inhibitors for cancer therapy using humanized mice","volume":"175","author":"Sugiyama","year":"2024","journal-title":"J. Biochem."},{"key":"B137","doi-asserted-by":"publisher","first-page":"104200","DOI":"10.1016\/j.ebiom.2022.104200","article-title":"Blockade of STAT3\/IL-4 overcomes EGFR T790M-cis-L792F-induced resistance to osimertinib via suppressing M2 macrophages polarization","volume":"83","author":"Sun","year":"","journal-title":"EBioMedicine"},{"key":"B138","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s40364-022-00436-7","article-title":"Targeting toll-like receptor 7\/8 for immunotherapy: recent advances and prospectives","volume":"10","author":"Sun","year":"","journal-title":"Biomark. Res."},{"key":"B139","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1038\/s41375-024-02391-8","article-title":"IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma","volume":"38","author":"Sun","year":"2024","journal-title":"Leukemia"},{"key":"B140","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s12672-025-02592-2","article-title":"Specific signaling pathways mediated programmed cell death in tumor microenvironment and target therapies","volume":"16","author":"Sun","year":"2025","journal-title":"Discov. Oncol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/s41423-024-01224-z","article-title":"Regulation of CD8+ T cells by lipid metabolism in cancer progression","volume":"21","author":"Tang","year":"2024","journal-title":"Cell Mol. Immunol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nature11986","article-title":"Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1","volume":"496","author":"Tannahill","year":"2013","journal-title":"Nature"},{"key":"B143","doi-asserted-by":"publisher","first-page":"110942","DOI":"10.1016\/j.cbi.2024.110942","article-title":"Comparing the oxidative functions of neutrophil myeloperoxidase and cytochrome P450 enzymes in drug metabolism","volume":"392","author":"Tran","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"B144","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.molcel.2016.09.013","article-title":"Direct regulation of alternative splicing by SMAD3 through PCBP1 is essential to the tumor-promoting role of TGF-\u03b2","volume":"64","author":"Tripathi","year":"2016","journal-title":"Mol. Cell"},{"key":"B145","doi-asserted-by":"publisher","first-page":"11180","DOI":"10.3390\/ijms222011180","article-title":"Tumor-associated microglia\/macrophages as a predictor for survival in glioblastoma and temozolomide-induced changes in CXCR2 signaling with new resistance overcoming strategy by combination therapy","volume":"22","author":"Urbantat","year":"","journal-title":"Int. J. Mol. Sci."},{"key":"B146","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.3390\/cancers13122983","article-title":"Advances in chemokine signaling pathways as therapeutic targets in glioblastoma","volume":"13","author":"Urbantat","year":"","journal-title":"Cancers (Basel)"},{"key":"B147","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.celrep.2016.09.008","article-title":"Mitochondrial dysfunction prevents repolarization of inflammatory macrophages","volume":"17","author":"Van den Bossche","year":"2016","journal-title":"Cell Rep."},{"key":"B148","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1210\/endrev\/bnad005","article-title":"Insulin\/IGF axis and the receptor for advanced glycation end products: role in meta-inflammation and potential in cancer therapy","volume":"44","author":"Vella","year":"2023","journal-title":"Endocr. Rev."},{"key":"B149","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.ijbiomac.2022.09.129","article-title":"A concise review of VEGF, PDGF, FGF, notch, angiopoietin, and HGF signalling in tumor angiogenesis with a focus on alternative approaches and future directions","volume":"221","author":"Vimalraj","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"553594","DOI":"10.3389\/fonc.2021.553594","article-title":"Comprehensive in silico analysis of a novel serum exosome-derived competitive endogenous RNA network for constructing a prognostic model for glioblastoma","volume":"11","author":"Wang","year":"","journal-title":"Front. Oncol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"56825","DOI":"10.1021\/acsami.1c12406","article-title":"Macrophage-mediated porous magnetic nanoparticles for multimodal imaging and postoperative photothermal therapy of gliomas","volume":"13","author":"Wang","year":"","journal-title":"ACS Appl. Mater Interfaces"},{"key":"B152","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1038\/s41467-022-30568-1","article-title":"STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"key":"B153","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","article-title":"Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance","volume":"8","author":"Wang","year":"","journal-title":"NPJ Precis. Oncol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.ccell.2024.03.013","article-title":"Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization","volume":"42","author":"Wang","year":"","journal-title":"Cancer Cell"},{"key":"B155","doi-asserted-by":"publisher","first-page":"1344705","DOI":"10.3389\/fcell.2024.1344705","article-title":"Exosomes: a promising avenue for cancer diagnosis beyond treatment","volume":"12","author":"Wang","year":"","journal-title":"Front. Cell Dev. Biol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s12672-024-01245-0","article-title":"Glutamine and leukemia research: progress and clinical prospects","volume":"15","author":"Wang","year":"","journal-title":"Discov. Oncol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"116605","DOI":"10.1016\/j.ejmech.2024.116605","article-title":"Discovery of novel CXCR4 inhibitors for the treatment of inflammation by virtual screening and biological evaluation","volume":"275","author":"Wang","year":"","journal-title":"Eur. J. Med. Chem."},{"key":"B158","doi-asserted-by":"publisher","first-page":"1617968","DOI":"10.3389\/fimmu.2025.1617968","article-title":"Cancer-associated fibroblasts in clear cell renal cell carcinoma: functional heterogeneity, tumor microenvironment crosstalk, and therapeutic opportunities","volume":"16","author":"Wang","year":"","journal-title":"Front. Immunol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"1563858","DOI":"10.3389\/fimmu.2025.1563858","article-title":"The solid tumor microenvironment and related targeting strategies: a concise review","volume":"16","author":"Wang","year":"","journal-title":"Front. Immunol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.ccell.2024.08.012","article-title":"Fibrotic response to anti-CSF-1R therapy potentiates glioblastoma recurrence","volume":"42","author":"Watson","year":"2024","journal-title":"Cancer Cell"},{"key":"B161","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1038\/s41467-025-57603-1","article-title":"Interleukin-16 enhances anti-tumor immune responses by establishing a Th1 cell-macrophage crosstalk through reprogramming glutamine metabolism in mice","volume":"16","author":"Wen","year":"2025","journal-title":"Nat. Commun."},{"key":"B162","doi-asserted-by":"publisher","first-page":"e10698","DOI":"10.15252\/emmm.201910698","article-title":"Lipid droplet-dependent fatty acid metabolism controls the immune suppressive phenotype of tumor-associated macrophages","volume":"11","author":"Wu","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"B163","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"B164","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40164-021-00230-5","article-title":"Blocking siglec-10(hi) tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma","volume":"10","author":"Xiao","year":"2021","journal-title":"Exp. Hematol. Oncol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12967-023-04810-3","article-title":"Matrix stiffness affects tumor-associated macrophage functional polarization and its potential in tumor therapy","volume":"22","author":"Xiong","year":"2024","journal-title":"J. Transl. Med."},{"key":"B166","doi-asserted-by":"publisher","first-page":"974996","DOI":"10.3389\/fimmu.2022.974996","article-title":"Origin, activation, and targeted therapy of glioma-associated macrophages","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Immunol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","article-title":"Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct. Target Ther."},{"key":"B168","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.it.2021.02.004","article-title":"Context-dependent glioblastoma-Macrophage\/Microglia symbiosis and associated mechanisms","volume":"42","author":"Xuan","year":"2021","journal-title":"Trends Immunol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12943-022-01513-z","article-title":"Glioma targeted therapy: insight into future of molecular approaches","volume":"21","author":"Yang","year":"2022","journal-title":"Mol. Cancer"},{"key":"B170","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1016\/j.apsb.2020.04.004","article-title":"The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy","volume":"10","author":"Yang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"B171","doi-asserted-by":"publisher","first-page":"5782","DOI":"10.1038\/s41467-022-33349-y","article-title":"CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis","volume":"13","author":"Yang","year":"2022","journal-title":"Nat. Commun."},{"key":"B172","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13046-024-02960-w","article-title":"T-cell infiltration and its regulatory mechanisms in cancers: insights at single-cell resolution","volume":"43","author":"Yang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B173","doi-asserted-by":"publisher","first-page":"189411","DOI":"10.1016\/j.bbcan.2025.189411","article-title":"Metabolic insights into TAMs and the tumor immune microenvironment: regulatory mechanisms and therapeutic interventions","volume":"1880","author":"Yang","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B174","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/s12276-020-00504-8","article-title":"Glutamine reliance in cell metabolism","volume":"52","author":"Yoo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"B175","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-023-01744-8","article-title":"Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments","volume":"22","author":"Yuan","year":"2023","journal-title":"Mol. Cancer"},{"key":"B176","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13578-021-00579-4","article-title":"Extracellular matrix: an important regulator of cell functions and skeletal muscle development","volume":"11","author":"Zhang","year":"","journal-title":"Cell Biosci."},{"key":"B177","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1186\/s12967-021-03181-x","article-title":"Cancer-associated fibroblasts promote oral squamous cell carcinoma progression through LOX-Mediated matrix stiffness","volume":"19","author":"Zhang","year":"","journal-title":"J. Transl. Med."},{"key":"B178","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12943-023-01725-x","article-title":"Roles of tumor-associated macrophages in anti-PD-1\/PD-L1 immunotherapy for solid cancers","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol. Cancer"},{"key":"B179","doi-asserted-by":"publisher","first-page":"45","DOI":"10.20892\/j.issn.2095-3941.2023.0440","article-title":"Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies","volume":"21","author":"Zhang","year":"2024","journal-title":"Cancer Biol. Med."},{"key":"B180","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jconrel.2021.11.028","article-title":"Nanomaterials targeting tumor associated macrophages for cancer immunotherapy","volume":"341","author":"Zhao","year":"2022","journal-title":"J. Control Release"},{"key":"B181","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41698-025-00920-x","article-title":"Exploring tumor-associated macrophages in glioblastoma: from diversity to therapy","volume":"9","author":"Zhao","year":"2025","journal-title":"NPJ Precis. Oncol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1158\/1535-7163.MCT-17-0634","article-title":"A spatio-temporal model of macrophage-mediated drug resistance in glioma immunotherapy","volume":"17","author":"Zheng","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"B183","doi-asserted-by":"publisher","first-page":"2006220","DOI":"10.1002\/adfm.202006220","article-title":"Macrophage-mediated tumor cell phagocytosis: opportunity for nanomedicine intervention","volume":"31","author":"Zhou","year":"2021","journal-title":"Adv. Funct. Mater"},{"key":"B184","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.3390\/molecules29246011","article-title":"CD36: the bridge between lipids and tumors","volume":"29","author":"Zhou","year":"2024","journal-title":"Molecules"},{"key":"B185","doi-asserted-by":"publisher","first-page":"101922","DOI":"10.1016\/j.mtbio.2025.101922","article-title":"Stealth missiles with precision guidance: a novel multifunctional nano-drug delivery system based on biomimetic cell membrane coating technology","volume":"33","author":"Zhou","year":"2025","journal-title":"Mater Today Bio"},{"key":"B186","doi-asserted-by":"publisher","first-page":"121558","DOI":"10.1016\/j.lfs.2023.121558","article-title":"Interaction of tumor-associated microglia\/macrophages and cancer stem cells in glioma","volume":"320","author":"Zhu","year":"2023","journal-title":"Life Sci."},{"key":"B187","doi-asserted-by":"publisher","first-page":"104570","DOI":"10.1016\/j.isci.2022.104570","article-title":"Multimodal imaging of the dynamic brain tumor microenvironment during glioblastoma progression and in response to treatment","volume":"25","author":"Zomer","year":"2022","journal-title":"iScience"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2025.1676338\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T05:30:43Z","timestamp":1758864643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2025.1676338\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":187,"alternative-id":["10.3389\/fcell.2025.1676338"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2025.1676338","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"article-number":"1676338"}}